Lay P. Khoo

11 Hospital Crescent
Singapore, 169610, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's Lymphoma.

Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's Lymphoma.

Journal: JCO precision oncology
Published: July 23, 2025

Using Deauville Scoring to Guide Consolidative Radiotherapy in Diffuse Large B-Cell Lymphoma.

Using Deauville Scoring to Guide Consolidative Radiotherapy in Diffuse Large B-Cell Lymphoma.

Journal: Cancers
Published: August 24, 2024

Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study.

Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study.

Journal: Leukemia & lymphoma
Published: July 21, 2023

An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma.

An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma.

Journal: Science translational medicine
Published: October 19, 2022

Clinicopathological factors affecting prognosis in marginal zone lymphoma in Asian patients: a cohort study.

Clinicopathological factors affecting prognosis in marginal zone lymphoma in Asian patients: a cohort study.

Journal: Leukemia & lymphoma
Published: June 10, 2022

A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.

A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.

Journal: American journal of hematology
Published: December 13, 2021

Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method.

Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method.

Journal: Leukemia & lymphoma
Published: October 19, 2021

Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.

Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.

Journal: Cancer reports (Hoboken, N.J.)
Published: March 28, 2021

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Journal: Leukemia
Published: March 09, 2021

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma.

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma.

Journal: Blood
Published: January 02, 2021

Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population.

Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population.

Journal: BMC cancer
Published: August 27, 2020

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Journal: Leukemia
Published: May 21, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026